
Minh D. Truong
Examiner (ID: 12235, Phone: (571)270-3014 , Office: P/3654 )
| Most Active Art Unit | 3654 |
| Art Unit(s) | 3654, 3619, 4187 |
| Total Applications | 866 |
| Issued Applications | 545 |
| Pending Applications | 76 |
| Abandoned Applications | 265 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6940546
[patent_doc_number] => 20050114109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'STRUCTURE OF INTEGRIN ALPHA V-beta 3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND'
[patent_app_type] => utility
[patent_app_number] => 10/503960
[patent_app_country] => US
[patent_app_date] => 2003-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12421
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20050114109.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503960 | STRUCTURE OF INTEGRIN ALPHA V-beta 3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND | Feb 6, 2003 | Abandoned |
Array
(
[id] => 6706324
[patent_doc_number] => 20030153058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Method for producing L-arginine'
[patent_app_type] => new
[patent_app_number] => 10/351306
[patent_app_country] => US
[patent_app_date] => 2003-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4376
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351306
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351306 | Method for producing L-arginine | Jan 26, 2003 | Abandoned |
Array
(
[id] => 7228857
[patent_doc_number] => 20050255544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Lipolytic enzyme variants and method for their production'
[patent_app_type] => utility
[patent_app_number] => 10/495597
[patent_app_country] => US
[patent_app_date] => 2003-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 5748
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255544.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495597 | Lipolytic enzyme variants and method for their production | Jan 15, 2003 | Abandoned |
Array
(
[id] => 6679064
[patent_doc_number] => 20030229205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Method for recombinant microorganism expression and isolation of collagen-like polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/342331
[patent_app_country] => US
[patent_app_date] => 2003-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22508
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10342331
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/342331 | Composition comprising a purified collagen-like polypeptide suitable as a peptizer | Jan 14, 2003 | Issued |
| 09/856200 | CRTSTALLOGRAPHY-RELATED METHOD FOR IDENTIFYING POTENTIAL INHIBITORS OF THE CD4-GP120 INTERACTION | Jan 2, 2003 | Abandoned |
Array
(
[id] => 7229060
[patent_doc_number] => 20050261836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof'
[patent_app_type] => utility
[patent_app_number] => 10/497767
[patent_app_country] => US
[patent_app_date] => 2002-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 75
[patent_no_of_words] => 18355
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10497767
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497767 | Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof | Dec 4, 2002 | Abandoned |
Array
(
[id] => 7033634
[patent_doc_number] => 20050032144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking'
[patent_app_type] => utility
[patent_app_number] => 10/494163
[patent_app_country] => US
[patent_app_date] => 2002-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5037
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494163
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494163 | Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking | Nov 14, 2002 | Abandoned |
Array
(
[id] => 7019266
[patent_doc_number] => 20050221285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Method for identifying or screening anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 10/492187
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 192504
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492187 | Method for identifying or screening anti-viral agents | Nov 7, 2002 | Abandoned |
Array
(
[id] => 7181813
[patent_doc_number] => 20050124791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Ion channel'
[patent_app_type] => utility
[patent_app_number] => 10/494860
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6945
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494860
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494860 | Ion channel | Nov 7, 2002 | Abandoned |
Array
(
[id] => 6697500
[patent_doc_number] => 20030109694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Novel process'
[patent_app_type] => new
[patent_app_number] => 10/288985
[patent_app_country] => US
[patent_app_date] => 2002-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4062
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10288985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/288985 | Novel process | Nov 5, 2002 | Abandoned |
Array
(
[id] => 6711093
[patent_doc_number] => 20030170842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Crystals of cytochrome P450 2C9, structures thereof and their use'
[patent_app_type] => new
[patent_app_number] => 10/280137
[patent_app_country] => US
[patent_app_date] => 2002-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 506
[patent_figures_cnt] => 506
[patent_no_of_words] => 35446
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10280137
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/280137 | Crystals of cytochrome P450 2C9, structures thereof and their use | Oct 24, 2002 | Abandoned |
Array
(
[id] => 5107017
[patent_doc_number] => 20070065895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Substrates specific to von willebrand factor cleaving protease and method of assaying the activity'
[patent_app_type] => utility
[patent_app_number] => 10/531427
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7695
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065895.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531427 | Substrate polyeptides for von Willebrand factor cleaving protease ADAMTS-13 | Oct 17, 2002 | Issued |
Array
(
[id] => 239592
[patent_doc_number] => 07592309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Method of using a peptide having analgesic and antitumor activity from scorpion'
[patent_app_type] => utility
[patent_app_number] => 10/491077
[patent_app_country] => US
[patent_app_date] => 2002-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3815
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592309.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491077
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491077 | Method of using a peptide having analgesic and antitumor activity from scorpion | Sep 28, 2002 | Issued |
Array
(
[id] => 6861065
[patent_doc_number] => 20030092073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => ' Method for sequence specific biotinylation'
[patent_app_type] => new
[patent_app_number] => 10/251313
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6418
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251313
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251313 | Method for sequence specific biotinylation | Sep 19, 2002 | Abandoned |
Array
(
[id] => 5851174
[patent_doc_number] => 20060234365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Methods of purification of cytochrome P450 proteins'
[patent_app_type] => utility
[patent_app_number] => 10/221036
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15914
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221036 | Methods of purification of cytochrome P450 proteins | Sep 8, 2002 | Abandoned |
Array
(
[id] => 6990934
[patent_doc_number] => 20050089971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Process for the preparation of d-pantothenic acid and/or its salts'
[patent_app_type] => utility
[patent_app_number] => 10/490851
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5566
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490851 | Process for the preparation of d-pantothenic acid and/or its salts | Aug 21, 2002 | Abandoned |
Array
(
[id] => 6851373
[patent_doc_number] => 20030143576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Method and device for integrated protein expression, purification and detection'
[patent_app_type] => new
[patent_app_number] => 10/225788
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10548
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225788
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225788 | Method and device for integrated protein expression, purification and detection | Aug 21, 2002 | Abandoned |
Array
(
[id] => 7116692
[patent_doc_number] => 20050069993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Process for the preparation of l-amino acids using strains of the enterobacteriaceae family'
[patent_app_type] => utility
[patent_app_number] => 10/481746
[patent_app_country] => US
[patent_app_date] => 2002-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4420
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481746
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481746 | Process for L-amino acid production using Enterobacteriaceae by enhancing ahpC or ahpF encoding alkyl hydroperoxide reductase | Jun 13, 2002 | Issued |
Array
(
[id] => 7263833
[patent_doc_number] => 20040241812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced pts-g expression'
[patent_app_type] => new
[patent_app_number] => 10/481743
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4428
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241812.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481743
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481743 | Process for L-amino acid production using enterobacteriaceae strain with enhanced ptsG expression | Jun 13, 2002 | Issued |
Array
(
[id] => 7196588
[patent_doc_number] => 20050164341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Methods of purification of cytochrome p450 proteins and of their crystallizing'
[patent_app_type] => utility
[patent_app_number] => 10/516338
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16339
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516338 | Methods of purification of cytochrome p450 proteins and of their crystallizing | May 29, 2002 | Abandoned |